FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > Question for Mil_Man54

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Sep 28, 2021 4:07pm

33 Views

Post# 33931938

RE:Question for Mil_Man54

I don't think I'm the right person to answer that......GrahamB, Reno, or Walter I believe are more versed in that type of analysis........any of you three want to take this question?......

TryN2Learn wrote: Hi Mil_Man54. You seem like you are very well educated. I was just reading on SEDAR for the document type Material Change Report filed on Sep 24 2021 that there was the issuance of 4,502,392 Class B Subordinate voting shares in the capital of FSD Pharma.

Does this mean that FSD Pharma created these shares in order to purchase Lucid? Any feedback would be greatly appreciated. Thank you.

<< Previous

Bullboard Posts

Next >>

This junior mining stock offers billions in market exposure